Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

salivaricin A

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The study sought to purify and characterize a novel bacteriocin from oral L. salivarius and studying the effect of L. salivarius… Expand
2015
2015
The image for Fig 3 is incorrect. Please see the corrected Fig 3 here. Fig 3 (a) Normalized distribution of detected… Expand
  • table 1
  • figure 1
  • figure 2
  • table 3
  • figure 3
2015
2015
ABSTRACT Streptococcus agalactiae (group B streptococcus [GBS]) colonizes the rectovaginal tract in 20% to 30% of women and… Expand
2014
2014
Microbial communities inhabiting the breast milk microenvironment are essential in supporting mammary gland health in lactating… Expand
  • figure 3
2012
2012
Bacteriocins are antimicrobial peptides with potential applications as therapeutic agents for the treatment of microbial… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2007
2007
The colonization efficacies of salivaricin A (SalA)-producing Streptococcus salivarius strains 20P3 and 5 were compared when… Expand
Highly Cited
2006
Highly Cited
2006
ABSTRACT Salivaricin A (SalA), the first Streptococcus salivarius lantibiotic to be characterized, appears to be inhibitory to… Expand
Highly Cited
2006
Highly Cited
2006
ABSTRACT The commercial probiotic Streptococcus salivarius strain K12 is the prototype of those S. salivarius strains that are… Expand
Highly Cited
2006
Highly Cited
2006
Streptococcus salivarius strains commonly produce bacteriocins as putative anticompetitor or signalling molecules. Here we report… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
1993
Highly Cited
1993
A bacteriocin-like inhibitory substance, salivaricin A, was purified from cultures of Streptococcus salivarius 20P3 and was shown… Expand